| Financial Year |
March 31 2023 |
| Monetary Funds |
493,121,931.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
108,419,369.06 |
| Accounts Receivable |
1,171,614,542.06 |
| Advances to Suppliers |
127,610,548.85 |
| Other Receivables |
48,306,393.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
757,801,841.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,221,217.83 |
| Total Current Assets |
2,783,981,708.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,716,725.16 |
| Fixed Assetes |
621,317,488.93 |
| Under-construction Projects |
123,912,105.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,000,453.62 |
| R&D expenses |
-- |
| Goodwill |
402,800,815.32 |
| Long-Term Deferred and Prepaid Expenses |
1,192,320.04 |
| Deferred Income Tax Assets |
51,539,188.34 |
| Other Non-Current Assets |
3,712,765.80 |
| Sub-Total of Non-Current Assets |
1,482,623,479.25 |
| Total Assets |
4,266,605,187.31 |
| Short-Term Loans |
642,947,937.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
77,061,917.91 |
| Accounts Payable |
488,620,757.49 |
| Accounts Received In Advance |
558,702.88 |
| Employee Compensation Payable |
10,182,604.03 |
| Taxes Payable |
24,209,173.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,055,817.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
131,432,129.21 |
| Other Current Liabilities |
9,587,108.19 |
| Sub-Total of Current Liabilities |
1,592,428,535.39 |
| Long-term Loans |
333,630,599.00 |
| Bonds Payable |
559,784,909.98 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,893,422.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
958,392,932.73 |
| Total Liabilities |
2,550,821,468.12 |
| Paid-In Capital(Or Share Stock) |
361,757,448.00 |
| Capital Surplus |
871,715,189.86 |
| Surplus Reserve |
60,472,156.34 |
| LESS:Treasury Stock |
10,991,610.00 |
| Undistributed Profits |
293,901,337.03 |
| Minority Stockholder's Interest |
11,445,115.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,704,338,604.06 |
| Owner's Equity（Stockholder's Equity） |
1,715,783,719.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,266,605,187.31 |
